-
From Screen to Reality The Impact of Movies on Modern Relationships
In the age of technology and social media, it’s no secret that movies have a significant impact on modern relationships. From romantic comedies to action-packed thrillers, we are constantly bombarded with images of love, passion, and drama on the big screen. But how does this constant exposure to fictional relationships shape our own real-life connections?…
-
The Rising Threat of Cyber Incidents
In today’s digital world, cyber incidents pose a significant risk to businesses of all sizes. From data breaches to ransomware attacks, organisations face a barrage of threats and unfortunately, the discussion has moved from “if” your organisation will be impacted by a cyber incident to “when” and “how many times.”…By: Epiq
-
Final Amendments to Regulation S-P under Securities Exchange Act of 1934
On May 15, 2024, the Securities and Exchange Commission (the “SEC”) issued final amendments (the “Amendments”) to Regulation S-P (originally adopted in 2000), which governs the treatment of a customer’s nonpublic personal information by certain financial institutions. The Amendments aim to modernize and enhance the customer protections established under Regulation S-P by expanding the scope…
-
GlaxoSmithKline Patient Health Info Leaked in Lash Group Data Breach
On May 24, 2024, the Lash Group filed a notice of data breach with the Attorney General of California after discovering that the protected health information of GlaxoSmithKline patients was leaked following a cyberattack against the Lash Group. In this notice, Lash Group explains that the incident resulted in an unauthorized party being able to…
-
Accelerated Approval Process Is Not Without Risk: Placing Recent FDA Action in Context
On February 23, the Food and Drug Administration (FDA) withdrew approval of Pepaxto (melphalan flufenamide), a drug that it had previously granted accelerated approval for treatment of multiple myeloma. The decision came after a post-marketing, confirmatory study of Pepaxto failed to confirm the drug’s clinical benefit, and FDA determined that available evidence demonstrated that Pepaxto…
-
Hackers Claim Cyberattack on American Clinical Solutions Resulted in Data Breach Impacting 400k Medical Records
Recently, reports began to emerge about a possible American Clinical Solutions, LLC (“ACS”) data breach. While ACS has not yet acknowledged a cyberattack or a subsequent data breach, hackers claim to have obtained consumers’ sensitive information, which includes their names, Social Security numbers, dates of birth, genders, patient ID numbers, laboratory results, policy numbers, insurance…
-
Gasket/Packing Manufacturer Prevails after Jury Trial
Court: United States District Court for the District of Massachusetts Decedent Arnold L. Pritt was diagnosed with singular mesothelioma, epithelioid type in September 2019. He alleged he was exposed to asbestos during his service in the U.S. Navy and as a civilian electrician….By: Goldberg Segalla
-
DOJ Seeks 10-Year Prison Sentences in First Consumer Product Safety Conviction
This month, the government is asking for a pair of 10-year prison sentences for two Gree USA Inc. executives convicted of failing to report defective humidifiers. This comes after the two were found guilty of conspiracy to defraud the US Consumer Product Safety Commission (“CPSC”) and of failing to satisfy the reporting requirements of the…
-
Middle East Crisis: Deadly Strike in Rafah Did Not Cross Biden’s Red Line, Officials Say
President Biden has threatened to cut off the supply of some weapons if Israel mounts a major offensive in Rafah. “We haven’t seen that,” a White House spokesman said.
-
Georgia’s Ruling Party Secures a Contentious Law on Foreign Influence
The Parliament, controlled by the Georgian Dream party, overrode a presidential veto of a bill critics say could undermine the country’s efforts to join the European Union.
